Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study
NCT06654895 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 700
Last updated 2026-02-03
Summary
The primary objective of this study is to validate a pre-defined IL-6 concentration cutoff that predicts 28-day mortality in patients who are admitted or are intended to be admitted to the ICU diagnosed with sepsis or septic shock.
Conditions
- Sepsis, Septic Shock
Sponsors & Collaborators
-
Bluejay Diagnostics, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 22 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-12
- Primary Completion
- 2026-08-30
- Completion
- 2026-08-30
Countries
- United States
Study Locations
More Related Trials
-
Septic Shock-induced Immunosuppression
NCT04067674 ·Status: RECRUITING
-
A Prospective Observational Study of Sepsis
NCT05309889 ·Status: UNKNOWN
-
POC SPLA2-IIA as a Biomarker for Sepsis and Septic Shock
NCT03953404 ·Status: UNKNOWN
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
NCT06491966 ·Status: RECRUITING
-
Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis
NCT02198950 ·Status: COMPLETED
-
Empiric Antibiotic Treatment for Septic Patients in the Intensive Care Unit
NCT05924126 ·Status: RECRUITING
-
Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis
NCT06446947 ·Status: RECRUITING
-
CD64 and Antibiotics in Human Sepsis
NCT02922998 ·Status: COMPLETED
-
Host Dysregulation-Driven Sepsis Prediction Model
NCT06523075 ·Status: COMPLETED
-
A Comparative Study Between Neutrophil/Lymphocyte Ratio and Lactate/Albumin Ratio as Predictive Inflammatory Markers for Sepsis
NCT07089524 ·Status: RECRUITING
-
Effect of Cytosorb on Blood Levels of Inflammatory Biomarkers of Sepsis.
NCT04226430 ·Status: COMPLETED
-
Evaluation of the Performance of the IDBIORIV Method in Pathogen Identification and Antibiotic Susceptibility Testing in Patients With Sepsis
NCT06219135 ·Status: RECRUITING
-
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT05681442 ·Status: RECRUITING ·Phase: PHASE4
-
Bacterial Infection Diagnosis Using Blood DNA
NCT00698919 ·Status: UNKNOWN
-
Clinical Validation of HostDx Sepsis™ on NanoString; a Prospective Observational Validation Trial
NCT04414189 ·Status: COMPLETED
-
Utility of Presepsin in Distinguishing Between Sepsis and SIRS
NCT02052895 ·Status: COMPLETED
-
Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections
NCT00934011 ·Status: COMPLETED ·Phase: NA
-
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
NCT01867905 ·Status: COMPLETED
-
Evaluation of the Performance of a New Rapid Bacteremia Test in the Intensive Care Patient
NCT06241248 ·Status: COMPLETED
-
Cytokine Response in Septic Shock
NCT01770457 ·Status: UNKNOWN
-
Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis
NCT05640037 ·Status: COMPLETED
-
Novel Sepsis Sub-phenotypes Based on Trajectories of Vital Signs
NCT05826223 ·Status: COMPLETED
-
Comparison Between the Progostic Value of the Procalcitonin and the Platelet/Total Leukocytic Count Ratio in Sepsis
NCT06991686 ·Status: COMPLETED
-
Prognostic Interest of Leucocyte Immunophenotyping During the Acute Phase of Sepsis
NCT01995448 ·Status: COMPLETED